Biohaven (BHVN) Capital Expenditures (2021 - 2025)

Biohaven has disclosed Capital Expenditures across 5 years of filings, most recently posting $8000.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $8000.0, down 83.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $254000.0 (down 93.76% YoY), and the FY2025 annual result was $715000.0, down 82.34% from the prior year.
• Capital Expenditures came in at $8000.0 for Q4 2025 at Biohaven, down from $13000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $4.5 million in Q3 2022 to a low of $8000.0 in Q4 2025.
• The 5-year median for Capital Expenditures is $461000.0 (2025), against an average of $828647.1.
• Across the five-year window, Capital Expenditures soared 395.63% in 2024 and plunged 97.87% in 2025, its largest moves.
• Biohaven's Capital Expenditures stood at $201000.0 in 2021, then surged by 49.25% to $300000.0 in 2022, then surged by 56.67% to $470000.0 in 2023, then plunged by 89.57% to $49000.0 in 2024, then sank by 83.67% to $8000.0 in 2025.
• The last three Capital Expenditures figures came in at $8000.0 (Q4 2025), $13000.0 (Q3 2025), and $233000.0 (Q2 2025), per Business Quant data.